SUNDAY June 1, 2014, 2014 — A new type of anti-estrogen drug appears to work better than the estrogen-blocking drug tamoxifen in preventing recurrences of breast cancer in certain women, a new study reports. Exemestane (Aromasin), which belongs to a class of drugs called aromatase…
Source:Newer Anti-Estrogen Treatment May Benefit Younger Breast Cancer Survivors
Sunday, June 1, 2014
Newer Anti-Estrogen Treatment May Benefit Younger Breast Cancer Survivors
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment